This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $11,642.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, with an ultimate completion date of December 4, 2024. The contract was not set aside for any specific business category....
This federal contract award is for the delivery of BOTOX 100 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order valued at $2,584.08 with a firm fixed price and an ultimate completion date of June 18, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This contract is not set aside for any specific business type....
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency that supports military healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $14,454.00 and a completion date of December 31, 2024. This award does not have a set-aside designation, indicating open competition....
The federal contract award is for the supply of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a major defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, in the amount of $23,285.20 on August 29, 2024. The contract has an ultimate completion date of September 20, 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award is for the delivery of 200-unit vials of BOTOX to the Defense Logistics Agency (DLA), a defense agency. The $10,257.48 firm-fixed-price delivery order contract was awarded on June 17, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of July 10, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on April 22, 2024 with a ceiling value of $27,360.11 and an ultimate completion date of May 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the provision of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a Delivery Order valued at $5,821.30. The award has an ultimate completion date of May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
The federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $63,236.25 and an ultimate completion date of January 7, 2025. The contract was awarded on December 13, 2024 and was not set aside for any specific business type. Amerisourcebergen Drug...
This federal contract award is for the delivery of BOTOX 200 UNIT VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract, a Delivery Order valued at $5,239.17, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a firm fixed-price pricing type and an ultimate completion date of November 29, 2024. This contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of BOTOX 100 UNIT VIALS to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $3,445.44 and an ultimate completion date of January 16, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant...